CID 135955742

Schembl13712300

Structural Information

Molecular Formula
C20H25N5O6S2
SMILES
CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C(C4CCCC4N(C3=O)NC5CCC5)O
InChI
InChI=1S/C20H25N5O6S2/c1-32(28,29)23-12-8-9-14-16(10-12)33(30,31)24-19(21-14)17-18(26)13-6-3-7-15(13)25(20(17)27)22-11-4-2-5-11/h8-11,13,15,22-23,26H,2-7H2,1H3,(H,21,24)
InChIKey
KPATXBCETTUWTL-UHFFFAOYSA-N
Compound name
N-[3-[1-(cyclobutylamino)-4-hydroxy-2-oxo-5,6,7,7a-tetrahydro-4aH-cyclopenta[b]pyridin-3-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

495.12463 Da
Monoisotopic Mass

0.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 496.13191 204.9
[M+Na]+ 518.11385 206.7
[M-H]- 494.11735 206.5
[M+NH4]+ 513.15845 204.9
[M+K]+ 534.08779 204.7
[M+H-H2O]+ 478.12189 191.8
[M+HCOO]- 540.12283 204.6
[M+CH3COO]- 554.13848 237.3
[M+Na-2H]- 516.09930 207.1
[M]+ 495.12408 212.0
[M]- 495.12518 212.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe